Granulomatosis With Polyangiitis Clinical Trials
2 recruiting trials for Granulomatosis With Polyangiitis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Granulomatosis With Polyangiitis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 4 is the largest group at 50% (1 studies); the largest phase groups are Phase 4: 1, Phase 1: 1.
Research is led by University of Sao Paulo General Hospital (1), IRIS Research and Development, LLC (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Dengue 1,2,3,4 (attenuated) vaccine (biological, 1 trial), followed by AB-101, Rituximab.
Track Granulomatosis With Polyangiitis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in...
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell...
This study will evaluate the safety and activity of AB-101 in combination with rituximab in B-cell associated autoimmune diseases where rituximab is currently FDA approved (e.g.,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Granulomatosis With Polyangiitis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Granulomatosis With Polyangiitis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Granulomatosis With Polyangiitis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.